Research Article
Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation
Article first published online: 11 JAN 2013
DOI: 10.1111/mmi.12124
© 2013 Blackwell Publishing Ltd
Additional Information
How to Cite
Roehrich, A. D., Guillossou, E., Blocker, A. J. and Martinez-Argudo, I. (2013), Shigella IpaD has a dual role: signal transduction from the type III secretion system needle tip and intracellular secretion regulation. Molecular Microbiology, 87: 690–706. doi: 10.1111/mmi.12124
Publication History
- Issue published online: 25 JAN 2013
- Article first published online: 11 JAN 2013
- Manuscript Accepted: 4 DEC 2012
Funded by
- Wellcome Trust. Grant Number: 088231
- University of Bristol
Summary
Type III secretion systems (T3SSs) are protein injection devices essential for the interaction of many Gram-negative bacteria with eukaryotic cells. While Shigella assembles its T3SS when the environmental conditions are appropriate for invasion, secretion is only activated after physical contact with a host cell. First, the translocators are secreted to form a pore in the host cell membrane, followed by effectors which manipulate the host cell. Secretion activation is tightly controlled by conserved T3SS components: the needle tip proteins IpaD and IpaB, the needle itself and the intracellular gatekeeper protein MxiC. To further characterize the role of IpaD during activation, we combined random mutagenesis with a genetic screen to identify ipaD mutant strains unable to respond to host cell contact. Class II mutants have an overall defect in secretion induction. They map to IpaD's C-terminal helix and likely affect activation signal generation or transmission. The Class I mutant secretes translocators prematurely and is specifically defective in IpaD secretion upon activation. A phenotypically equivalent mutant was found in mxiC. We show that IpaD and MxiC act in the same intracellular pathway. In summary, we demonstrate that IpaD has a dual role and acts at two distinct locations during secretion activation.

1365-2958/asset/olbannerleft.gif?v=1&s=5badf94c134fc8798f790efd4821c55ff95fc4cb)
